AGP Executive Report
Last update: 7 hours agoAbortion Law Debate in Liechtenstein: A new push to modernise Liechtenstein’s strict abortion rules is running into resistance from Hereditary Prince Alois, who has threatened to use his royal veto again—keeping the country among Europe’s most restrictive. Cancer Drug Access: IMPACT Therapeutics and Pharmanovia signed an exclusive licensing deal for senaparib, aiming to expand maintenance treatment for advanced ovarian, fallopian tube, and primary peritoneal cancer across 66 countries, including Liechtenstein and the wider EU, with payments potentially reaching €423.5m. Hepatitis B Hope: Researchers across Europe are working toward a “functional cure” for chronic hepatitis B, where vaccines prevent new infections but today’s medicines can’t fully eliminate the virus. Healthcare Data Breach: Brown Health Medical Group-MA says a December 2025 incident exposed personal, medical, and financial data for 311,000 people, even though its electronic health record system wasn’t affected. Public Health & Safety: UK customs rules are tightening for travellers returning with meat and dairy—cheese, milk products, and several meats are restricted from EU/Switzerland/Norway/Iceland/Liechtenstein routes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
